GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says - San Jose Mercury News
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced..
How 'bout some jail?
2 comments:
That's a lot of money, and that makes me suspicious.
Yeah. It's one thing to levy; it's another to collect and yet another to disburse.
Post a Comment